SAN FRANCISCO--(BUSINESS WIRE)-- Cannabis Science Inc. (NASD OTCBB: CBIS), an emerging pharmaceutical cannabis company, is pleased to announce the appointment of Dr. Robert J. Melamede, Ph.D., as President & CEO, replacing Steven W. Kubby in that position. Mr. Kubby will remain as a Director and the company is in discussions with him about his future role.
PreferredSeries A Stock Richard Cowan Shareholder 333,333 = 30.1%
Common Stock: Richard Cowan Shareholder 8,507,00 = 7.9%
4. Mr. Cowan is our Chief Financial Officer and a Director.
CBIS
(imo)
Don't be fooled by board counts, my stock #'s, followers etc. Your own DD is what should drive your investments. You are responsible for your investment choices.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.